This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Sep;15(5):351-353.

doi: 10.2217/pme-2018-0036. Epub 2018 Sep 27.

Precision medicine in oncology: what is it exactly and where are we?

Christophe Le Tourneau^{1

2

3}, Maud Kamal¹, Ivan Bièche⁴

Affiliations

Affiliations

¹ Department of Drug Development & Innovation, Institut Curie, Paris & Saint-Cloud, France.
² INSERM U900 Research Unit, Institut Curie, Saint-Cloud, France.
³ Oncology University Department, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.
⁴ Pharmacogenomics Unit, Institute Curie, Paris, France.

PMID: 30260312
DOI: 10.2217/pme-2018-0036

Editorial

Precision medicine in oncology: what is it exactly and where are we?

Christophe Le Tourneau et al. Per Med. 2018 Sep.

. 2018 Sep;15(5):351-353.

doi: 10.2217/pme-2018-0036. Epub 2018 Sep 27.

Authors

Christophe Le Tourneau^{1

2

3}, Maud Kamal¹, Ivan Bièche⁴

Affiliations

¹ Department of Drug Development & Innovation, Institut Curie, Paris & Saint-Cloud, France.
² INSERM U900 Research Unit, Institut Curie, Saint-Cloud, France.
³ Oncology University Department, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.
⁴ Pharmacogenomics Unit, Institute Curie, Paris, France.

PMID: 30260312
DOI: 10.2217/pme-2018-0036

No abstract available

Keywords: SHIVA01; immunotherapy; oncology; precision medicine; predictive biomarker; prognostic biomarker; sequencing; targeted therapy.

PubMed Disclaimer

Similar articles

Precision medicine in pediatric oncology.
Forrest SJ, Geoerger B, Janeway KA. Forrest SJ, et al. Curr Opin Pediatr. 2018 Feb;30(1):17-24. doi: 10.1097/MOP.0000000000000570. Curr Opin Pediatr. 2018. PMID: 29189430 Free PMC article. Review.
Perspective on Precision Medicine in Oncology.
Johnson TM. Johnson TM. Pharmacotherapy. 2017 Sep;37(9):988-989. doi: 10.1002/phar.1975. Epub 2017 Aug 7. Pharmacotherapy. 2017. PMID: 28632968 Free PMC article. Review.
Precision oncology: Charting a path forward to broader deployment of genomic profiling.
Schram AM, Berger MF, Hyman DM. Schram AM, et al. PLoS Med. 2017 Feb 21;14(2):e1002242. doi: 10.1371/journal.pmed.1002242. eCollection 2017 Feb. PLoS Med. 2017. PMID: 28222135 Free PMC article.
Pediatric oncology enters an era of precision medicine.
Seibel NL, Janeway K, Allen CE, Chi SN, Cho YJ, Glade Bender JL, Kim A, Laetsch TW, Irwin MS, Takebe N, Tricoli JV, Parsons DW. Seibel NL, et al. Curr Probl Cancer. 2017 May-Jun;41(3):194-200. doi: 10.1016/j.currproblcancer.2017.01.002. Epub 2017 Feb 1. Curr Probl Cancer. 2017. PMID: 28343740
Current-day precision oncology: from cancer prevention, screening, drug development, and treatment - have we fallen short of the promise?
Morgan G, Aftimos P, Awada A. Morgan G, et al. Curr Opin Oncol. 2016 Sep;28(5):441-6. doi: 10.1097/CCO.0000000000000318. Curr Opin Oncol. 2016. PMID: 27428363 Review.

See all similar articles

Cited by

Favoring the hierarchical constraint in penalized survival models for randomized trials in precision medicine.
Belhechmi S, Le Teuff G, De Bin R, Rotolo F, Michiels S. Belhechmi S, et al. BMC Bioinformatics. 2023 Mar 16;24(1):96. doi: 10.1186/s12859-023-05162-x. BMC Bioinformatics. 2023. PMID: 36927444 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations